Furthermore, it seems that the combination of MMP/TIMP at the leading margin of each tumor may be able to create a fine-tuned microenvironment, regardless of MMP expression or baseline oncogenic BRAF mutation. The gene discussed is BRAF; the disease is neoplasm.